VijayPD Ceutical Ltd

VijayPD Ceutical Ltd maintains a debt-to-equity ratio of 0.68 and a current ratio of 1.9, indicating moderate leverage and adequate short-term liquidity to cover its obligations. However, the company's operating cash flow is negative at -78.87 million INR, while free cash flow stands at 47.34 million INR, suggesting that capital expenditures are being funded through operational cash flows. The company's profitability is reflected in a return on equity (ROE) of 14.91% and a return on assets (ROA) of 8.39%, both of which are strong indicators of efficient capital utilization and asset management. These metrics are in line with the industry's preferred metrics for profitability and returns, which emphasize ROE and ROA as key performance indicators. VijayPD Ceutical Ltd operates in a concentrated geographic market, with its distribution warehouses located in Mumbai and deliveries extending to Western Suburban Mumbai, South Mumbai, Ratnagiri, Aurangabad, and Akola. The company's revenue is primarily derived from the pharmaceutical and consumer goods sectors, with no disclosed segmental breakdown, indicating a lack of diversification in its product offerings. The company's growth trajectory is not clearly defined, as there are no specific numeric deltas provided for the current or next fiscal year. However, the company's revenue of 1.17 billion INR and gross profit of 182.26 million INR suggest a stable revenue base. The absence of detailed outlook data implies that the company's future performance is subject to market conditions and operational efficiency. The risk assessment for VijayPD Ceutical Ltd indicates a medium liquidity risk and a low dilution risk. A key flag is the negative net cash position after subtracting total debt, which could impact the company's ability to meet long-term obligations. The company's dilution potential is low, with no significant adjustments applied to the valuation metrics. Recent events and filings for VijayPD Ceutical Ltd are not detailed in the provided data, which limits the ability to assess the company's recent strategic moves or operational changes. The lack of recent transcript data or filings suggests that the company may not be actively disclosing new developments or strategic initiatives.